The true nature of pharmacogenomic associations?

Author： McCarthy J.  

Publisher： Elsevier

ISSN： 0165-6147

Source： Trends in Pharmacological Sciences, Vol.21, Iss.12, 2000-12, pp. : 461-461

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Architecture of pharmacogenomic associations: structures with functional foundations or castles made of sand?

By Glubb Dylan M   Innocenti Federico  

Pharmacogenomics, Vol. 14, Iss. 1, 2013-01 ,pp. : 1-4

Future Medicine

Access to resources Recommend Favorite

A pharmacogenomic evaluation of migraine therapy

By Johnson Matthew P   Fernandez Francesca   Colson Natalie J   Griffiths Lyn R  

Expert Opinion on Pharmacotherapy, Vol. 8, Iss. 12, 2007-08 ,pp. : 1821-1835

Informa Healthcare

Access to resources Recommend Favorite

Pharmacogenomic considerations for immunosuppressive therapy

By Yagil Yoram   Yagil Chana  

Pharmacogenomics, Vol. 4, Iss. 3, 2003-05 ,pp. : 309-319

Future Medicine

Access to resources Recommend Favorite

Pharmacogenomic biomarkers for personalized medicine

By Chen James J   Lin Wei-Jiun   Chen Hung-Chia  

Pharmacogenomics, Vol. 14, Iss. 8, 2013-06 ,pp. : 969-980

Future Medicine

Access to resources Recommend Favorite

Pharmacogenomic considerations of the paraoxonase polymorphisms

By Furlong Clement E   Cole Toby B   Jarvik Gail P   Costa Lucio G  

Pharmacogenomics, Vol. 3, Iss. 3, 2002-05 ,pp. : 341-348

Future Medicine

Access to resources Recommend Favorite